Day: November 28, 2023

Global award commends Upwork’s reliable, high-quality product offerings and recognizes the company’s dual-sided approach to delivering for companies and talentFrost & Sullivan 2023 New Product Innovation AwardUpwork has been recognized for its valuable achievements in innovation and growth in the global hiring platforms industry with the 2023 New Product Innovation Award from industry analyst firm Frost & Sullivan.SAN FRANCISCO, Nov. 28, 2023 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent from across the globe, today announced that the company was recognized for its valuable achievements in innovation and growth in the global hiring platforms industry with the 2023 New Product Innovation Award from industry analyst firm Frost...

NEC invests in “ERA Investors Fund 8”; ERA is New York City’s first and leading technology accelerator and early-stage venture capital fund PALO ALTO, Calif. and NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) — NEC X, Inc., the pioneering venture studio backed by NEC Corporation’s world-class technological innovation and expertise, and Entrepreneurs Roundtable Accelerator (ERA) today announced the establishment of a strategic partnership to strengthen support for entrepreneurs, which includes NEC’s investment in ERA Investors Fund 8. ERA focuses on early-stage startups and has invested in over 300 startups to date. ERA companies are innovating in a variety of significant industries, all with businesses ready to take advantage of its platform of more than 1,000 expert mentors and its experienced team for helping early-stage companies...

PALO ALTO, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the intent to unlock and maximize shareholder value. In consultation with financial and legal advisors, the Company intends to consider a broad range of strategic, operational and financial alternatives, and is exploring a full range of options. There is no assurance that the strategic review process will result in the approval or completion of any specific transaction or outcome. 180 Life Sciences has not established a timeline for completion of the review process and does not intend to comment further unless and until its Board of Directors has approved a definitive course of action,...

PALO ALTO, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has entered into an agreement with a leading pharmacy chain in the U.S. to stock ELYXYB® in over 500 stores which do not currently stock ELYXYB®. Scilex is also in the process of negotiating similar potential stocking arrangements with other major pharmacy chains in the U.S. Clinicians in a recent market research study expressed their desire for fast and safe alternatives for two large pools of acute migraine patients – those who have an insufficient response to triptan therapy, and those who have contraindications to triptan...

Sage Construction Management enhances Sage’s cloud construction portfolio to include complete end-to-end solutions for construction projects of all sizes TORONTO, Nov. 28, 2023 (GLOBE NEWSWIRE) — Sage, the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses (SMBs), today announces the launch of Sage Construction Management in Canada. Sage is expanding its construction cloud suite with the addition of cloud pre-construction and project management capabilities to its industry-leading construction portfolio. “Sage is proud to offer the only true cloud solutions built for construction with full end-to-end capabilities covering preconstruction, operations, and financials,” said Julie Adams, Vice President of Product, Construction and Real Estate, Sage. “Sage has been an industry leader at the...

BOISE, Idaho, Nov. 28, 2023 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) (the “Company”) today announced that it is updating its revenue, gross margin, operating expense, and EPS guidance for the first quarter of fiscal 2024, which ends Nov. 30, 2023. The Company previously guided revenue of $4.4 billion ± $200 million and non-GAAP gross margins of (4.0%) ± 2%. As a result of improved supply and demand balance and improved pricing, the Company today announced that it expects revenue will approach $4.7 billion and non-GAAP gross margins will approach breakeven for the first quarter of fiscal 2024. The Company announced additional updates as set forth in the tables below. Micron President and Chief Executive Officer Sanjay Mehrotra and Executive Vice President and Chief Financial Officer Mark Murphy will share further...

Data reveals that patient responsibility is a critical lever to improve financial health of hospitals 83% of CFOs and finance leaders surveyed said better technology would help them shorten the revenue cycle BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) — 85% of healthcare CFOs and senior financial leaders Flywire recently surveyed agree they need to do more to improve their collection/payment experience, and that they’re losing critical time and money because of it. These are a few of the findings from a new research report commissioned by Flywire (Nasdaq: FLYW), a global payments enablement and software company, which reveals that by improving the overall patient payment experience, hospitals and health systems can control costs and maximize revenue. For its latest healthcare report, “Why patient payments should be a top priority for...

WISeKey’s Subsidiary, SEALSQ, to Increase Investments in AI-Enhanced Semiconductors and IoT Innovations Over the Next Five Years To date, WISeKey has invested over $17 million for the development of a cutting-edge SEALSQ IoT Cybersecurity Platform and a Post Quantum Chip to be enhanced by AI These investments aim to integrate AI, foster the creation of sophisticated predictive IoT analysis systems, and improve operational efficiency and security of IoT devices   GENEVA – November 28, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions, operating as a holding company, in conjunction with its subsidiary SEALSQ Corp (NASDAQ: LAES) (“SEALSQ”), today announced its intention to increase its investments in Artificial Intelligence...

28 November 2023 News ReleasePharma Equity Group2024 Financial Calendar​March 4 Deadline for shareholder proposals – Annual General meeting​​March 20 ​Annual Report 2023​April 16 Annual General Meeting​May 16 Interim Report – for the three-month period ended March 31, 2024​August 16 Interim Report – for the six-month period ended June 30, 2024​November 15 Interim Report – for the nine-month period ended September 30, 2024​ Contact person – Investor Relations On the Company’s website www.pharmaequitygroup.com further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114 E-mail: investor@pharmaequitygroup.com. About Pharma Equity Group A/S Pharma Equity Group, a listed...

TEL AVIV, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its Board of Directors (the “Board”) has unanimously adopted a limited duration shareholder rights plan (the “Rights Plan”), effective immediately. “Today we announced exciting positive results from our weight loss and metabolic disorder program with our proprietary psychedelic-based treatment,” said Oz Adler, SciSparc’s Chief Executive Officer. “Unfortunately, SciSparc, like many other clinical-stage pharmaceutical companies, continues to experience a significant and ongoing dislocation in the trading price of...